Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07575633
Ultrasound Versus Virtual Reality on Temporomandibular DisorderAmany Refaat Mohamed Abdel WahidNot Yet RecruitingNot Applicable
NCT07575633Not Yet Recruiting
Not Applicable
Ultrasound Versus Virtual Reality on Temporomandibular DisorderAmany Refaat Mohamed Abde...
NCT07576010
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host DiseaseDaihong LiuActive Not RecruitingPhase 1
NCT07576010Active Not Recruiting
Phase 1
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graf...Daihong Liu
NCT07576595
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansLouisiana State University Health Sciences Center in New OrleansRecruitingNot Applicable
NCT07576595Recruiting
Not Applicable
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Amo...Louisiana State Universit...
NCT07576868
A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)Hyundai Bioscience Co., Ltd.RecruitingPhase 2
NCT07576868Recruiting
Phase 2
A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) a...Hyundai Bioscience Co., L...
NCT07575594
The Use of White Noise and Quiet Time During LaborIstanbul University - CerrahpasaCompleted
NCT07576608
A Phase II Study of 9MW3811 in Patients With Pathological ScarMabwell (Shanghai) Bioscience Co., Ltd.RecruitingPhase 2
NCT07576608Recruiting
Phase 2
A Phase II Study of 9MW3811 in Patients With Pathological ScarMabwell (Shanghai) Biosci...
NCT07574463
Adaptive Digital Exercise Rehabilitation for Children After CHD SurgeryBeijing Children's HospitalNot Yet RecruitingNot Applicable
NCT07574463Not Yet Recruiting
Not Applicable
Adaptive Digital Exercise Rehabilitation for Children After CHD SurgeryBeijing Children's Hospit...
NCT07574801
Postoperative Pain Following Root Canal Treatment With Bioceramic SealersCairo UniversityNot Yet RecruitingNot Applicable
NCT07574801Not Yet Recruiting
Not Applicable
Postoperative Pain Following Root Canal Treatment With Bioceramic SealersCairo University
NCT07575334
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fudan UniversityRecruitingNot Applicable
NCT07575334Recruiting
Not Applicable
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fud...
NCT07574853
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodontal Bone Tissue RegenerationThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07574853Not Yet Recruiting
Not Applicable
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodont...The First Affiliated Hosp...
NCT07574918
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin MedicalNot Yet RecruitingNot Applicable
NCT07574918Not Yet Recruiting
Not Applicable
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin Medical
NCT07575516
Effectiveness of Ashwagandha in Schizophrenia Patients on RisperidoneHasanuddin UniversityCompletedPhase 2
NCT07575516Completed
Phase 2
Effectiveness of Ashwagandha in Schizophrenia Patients on RisperidoneHasanuddin University
NCT07575126
Comparison of Qigong and Otago in Patient With Diabetic NeuropathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07575126Not Yet Recruiting
Not Applicable
Comparison of Qigong and Otago in Patient With Diabetic NeuropathyRiphah International Univ...
NCT07575373
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Intervention to Improve Transitions to Follow-Up Care for Hospitalized Patients With Substance Use DisordersMichael InczeNot Yet RecruitingNot Applicable
NCT07575373Not Yet Recruiting
Not Applicable
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Interventi...Michael Incze
NCT07574658
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample: a Study Protocol of a Randomized Clinical TrialUniversity of Sao PauloNot Yet RecruitingPhase 3
NCT07574658Not Yet Recruiting
Phase 3
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample:...University of Sao Paulo
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07575841
Pulmonary Rehabilitation Frequency in COPD PatientsHospital Universitario Fundación AlcorcónNot Yet RecruitingNot Applicable
NCT07575841Not Yet Recruiting
Not Applicable
Pulmonary Rehabilitation Frequency in COPD PatientsHospital Universitario Fu...
NCT07574944
Effectiveness of Simulation-based Training Delivered to Special Newborn Care Providers on Resuscitation Management and Kangaroo Mother Care: Simulation-based Training for Asyphxia in Babies Trial (STAR-Baby Trial)Development and Research Service International NepalNot Yet RecruitingNot Applicable
NCT07574944Not Yet Recruiting
Not Applicable
Effectiveness of Simulation-based Training Delivered to Special Newborn Care Pro...Development and Research...
NCT07575230
Suzetrigine vs Norco-PostOp Mohs PainBaylor Research InstituteEnrolling By InvitationPhase 4
NCT07575230Enrolling By Invitation
Phase 4
Suzetrigine vs Norco-PostOp Mohs PainBaylor Research Institute
Result Breakdown
Not yet recruiting12 (60%)
Recruiting4 (20%)
Completed2 (10%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable12 (60%)
Phase 24 (20%)
Phase 11 (5%)
Not Specified1 (5%)
Phase 31 (5%)
Phase 41 (5%)